Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Capital Raise

Every capital raise filing by a US-listed company that our alert engine sent, newest first.

4:48 PM ET 8-K
Capital Raise KKR Enhanced US Direct Lending Fund-L Inc.

KKR Enhanced US Direct Lending Fund-L Capital Raise of $70M

KKR Enhanced US Direct Lending Fund-L Inc. issued and sold 69,843 common shares to KKR Enhanced US Direct Lending Fund-L Holdings L.P. for $70.00 million. The transaction was conducted as part of the company's continuous private offering in reliance on Section 4(a)(2) and Regulation D exemptions.

Value
$70M
Counterparty
KKR Enhanced US Direct Lending Fund-L Holdings L.P.
4:34 PM ET 8-K
Capital Raise Strive, Inc. ASST

Strive Capital Raise of $500M

Strive, Inc. announced a proposed initial public offering of 5,000,000 shares of its 15.00% Series A Perpetual SATS Preferred Stock at a stated amount of $100 per share. The company intends to use the $500 million in gross proceeds for general corporate purposes, including the acquisition of bitcoin and bitcoin-related products, and to establish an 18-month dividend reserve.

Value
$500M
4:04 PM ET 8-K
Capital Raise Grayscale Bittensor Trust (TAO) GTAO

Grayscale Bittensor Trust Capital Raise of $1.45M

Grayscale Bittensor Trust (TAO) issued 253,100 shares to accredited investors in private placement transactions exempt from registration under Rule 506(c). The trust received an aggregate of 4,777.99171760 TAO tokens, valued at approximately $1.45 million, in exchange for the shares. As of October 13, 2026, the trust has 3,247,300 shares issued and outstanding.

Value
$1.45M
Counterparty
accredited investors
12:20 PM ET 8-K
Capital Raise Bridgecrest Lending Auto Securitization Trust 2026-4

Bridgecrest Lending Auto Securitization Trust 2026-4 Capital Raise

Bridgecrest Lending Auto Securitization Trust 2026-4 is filing legal and tax opinions in connection with the issuance of several classes of Auto Loan Asset Backed Notes (Class A-1 through Class D). This filing satisfies regulatory undertakings related to a takedown from an existing registration statement for the public offering of these asset-backed securities.

8:01 AM ET 8-K
Capital Raise Strategy Inc MSTR

Strategy Capital Raise of $21M

Strategy Inc raised $21.0 million in net proceeds through the sale of 125,183 shares of Class A Common Stock under its at-the-market (ATM) offering program between October 5 and October 11, 2026. The proceeds were used to fund the acquisition of 250 bitcoin, bringing the company's total holdings to 848,250 BTC. Additionally, the company repurchased $192.4 million of its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) during the same period.

Value
$21M
6:30 AM ET 8-K
Capital Raise Formfactor Inc FORM

Formfactor Capital Raise of $300M

FormFactor entered into a Securities Purchase Agreement with Teradyne, Inc. for a $300 million strategic equity investment via a private placement of 2,234,887 shares of common stock. The transaction is part of a broader technology collaboration aimed at accelerating semiconductor testing for AI, high-performance computing, and advanced packaging applications.

Value
$300M
Counterparty
Teradyne, Inc.
6:27 AM ET 8-K
Capital Raise ADC Therapeutics SA ADCT

ADC Therapeutics Capital Raise of $86.6M

ADC Therapeutics entered into securities purchase agreements for a $86.6 million private placement (PIPE) involving the sale of 12.9 million common shares and 48.1 million pre-funded warrants. The financing included participation from new investor Bain Capital Life Sciences and existing investors Redmile, TCGX, and Nantahala Capital. Proceeds will be used to fund ZYNLONTA pipeline studies and extend the company's cash runway into 2029.

Value
$86.6M
Counterparty
Bain Capital Life Sciences
5:25 PM ET 8-K
Capital Raise Sunshine Biopharma Inc. SBFM

Sunshine Biopharma Capital Raise of $6M

Sunshine Biopharma Inc. closed a best efforts public offering of approximately 10.9 million units for gross proceeds of $6.0 million. Each unit, priced at $0.55, consists of one share of common stock (or a pre-funded warrant) and two Series D warrants. The company intends to use the net proceeds for general corporate purposes and working capital.

Value
$6M
Counterparty
Aegis Capital Corp.
5:21 PM ET 8-K
Capital Raise Flyte Aviation, Inc. VJET

Flyte Aviation Capital Raise of $2.05M

Flyte Aviation, Inc. entered into an agreement with existing investors to sell 2,050 shares of Series C-4 Convertible Preferred Stock for gross proceeds of $2.05 million. The preferred shares are convertible into common stock at a price of $1.00 per share. Additionally, the company reduced the conversion price of all outstanding Series C, Series D, and Series J preferred stock to $1.00 per share.

Value
$2.05M
5:19 PM ET 8-K
Capital Raise Arrive AI Inc. ARAI

Arrive AI Capital Raise

Arrive AI Inc. closed a $250,000 private placement (PIPE) with an accredited investor, issuing 384,615 shares of common stock and warrants at a purchase price of $0.65 per unit. The investment was priced at a 213% premium to the company's recent trading price, and the investor expressed interest in evaluating up to $10 million in additional future financing.

5:03 PM ET 8-K
Capital Raise Crescent Energy Co CRGY

Crescent Energy Capital Raise of $1.15B

Crescent Energy Company priced an underwritten public offering of 80,000,000 shares of Class A Common Stock at $12.50 per share, with underwriters fully exercising their option for an additional 12,000,000 shares. The company expects to receive approximately $1,115.9 million in net proceeds, which will be used to fund the cash consideration for its acquisition of Eagle Ford assets from Devon Energy. KKR & Co. Inc. affiliates participated in the offering by purchasing 40,000,000 shares at the public offering price.

Value
$1.15B
Counterparty
J.P. Morgan Securities LLC
5:01 PM ET 8-K
Capital Raise Sintx Technologies, Inc. SINT

Sintx Technologies Capital Raise of $2.01M

SINTX Technologies received approximately $2.01 million in gross proceeds from the exercise of Class B Common Stock Purchase Warrants. The company issued 651,204 shares of common stock and 290,219 pre-funded warrants at an exercise price of $2.14 per share, while unexercised Class B warrants expired.

Value
$2.01M
4:31 PM ET 8-K
Capital Raise bioAffinity Technologies, Inc. BIAF

bioAffinity Technologies Capital Raise of $4M

bioAffinity Technologies entered into a securities purchase agreement with an institutional investor to raise approximately $4 million in gross proceeds. The offering consists of 116,545 shares of common stock and pre-funded warrants for 536,836 shares, priced at $6.122 and $6.115 respectively, alongside a private placement of unregistered warrants.

Value
$4M
Counterparty
institutional investor
4:05 PM ET 8-K
Capital Raise Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Capital Raise

Cheetah Net Supply Chain Service Inc. entered into a securities purchase agreement with its CEO, Huan Liu, to sell 100,000 shares of Class B common stock in a private placement. The transaction generated gross proceeds of $330,000 at a purchase price of $3.30 per share. The sale was conducted as an unregistered sale of equity securities exempt from registration under Regulation S or Section 4(a)(2).

Counterparty
Huan Liu
4:02 PM ET 8-K
Capital Raise Mangoceuticals, Inc. MGRX

Mangoceuticals Capital Raise

Mangoceuticals, Inc. entered into a securities purchase agreement for a registered direct offering of 657,000 shares of common stock and accompanying warrants to purchase up to 657,000 additional shares. The offering was priced at $0.75 per unit, representing a 74% premium to the recent market close, and is expected to generate gross proceeds of approximately $492,750 for working capital and general corporate purposes.

Counterparty
certain investors
6:18 AM ET 8-K/A
Capital Raise Atrium Therapeutics, Inc. RNA

Atrium Therapeutics Capital Raise

Atrium Therapeutics filed an amendment to correct the post-offering share count following a PIPE transaction involving 5,170,384 shares of common stock and pre-funded warrants for 1,134,930 shares. The company expects to have 21,571,507 shares outstanding after the closing of the offering and the settlement of spin-off related equity awards.

Counterparty
PIPE Investors
5:15 PM ET 8-K
Capital Raise Southport Acquisition Corp. II PORT

Southport Acquisition Corp. II Capital Raise of $218M

Southport Acquisition Corp. II consummated its initial public offering of 21,000,000 units at $10.00 per unit, raising $210 million in gross proceeds. Simultaneously, the company raised an additional $7.7 million through a private placement of 770,000 units to its sponsor and underwriters. A total of $212.1 million was placed into a trust account following the closing.

Value
$218M
Counterparty
Southport Acquisition Sponsor II LLC
4:46 PM ET 8-K
Capital Raise Vivos Inc RDGL

Vivos Capital Raise

Vivos Inc. entered into a Stock Purchase and Exchange Agreement with a member of its Board of Directors, Carl Cadwell, for the purchase of 250,000 shares of Series D Convertible Preferred Stock for $250,000. Additionally, the director exchanged 385,302 shares of Series C Preferred for an equal number of Series D shares, resulting in the elimination of the Series C class. The Series D shares have a conversion price of $0.08 per share.

Counterparty
Carl Cadwell
4:00 PM ET 8-K
Capital Raise Zoomcar Holdings, Inc. ZCAR

Zoomcar Holdings Capital Raise

Zoomcar Holdings, Inc. has extended the scheduled termination date of its ongoing bridge financing offering from October 09, 2026, to November 16, 2026. The extension was made with the agreement of the placement agent and applies to the securities purchase agreements entered into with investors.

3:32 PM ET 8-K
Capital Raise Ford Credit Floorplan Master Owner Trust a

Ford Credit Floorplan Master Owner Trust a Capital Raise

Ford Credit Floorplan Master Owner Trust A entered into an underwriting agreement for the issuance of Series 2026-4 asset-backed notes. The agreement was signed with a syndicate of underwriters led by Barclays, Deutsche Bank, Mizuho, BMO, and J.P. Morgan. The filing includes the required CEO certifications for shelf offerings of asset-backed securities.

Counterparty
Barclays Capital Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, BMO Capital Markets Corp. and J.P. Morgan Securities LLC
3:31 PM ET 8-K
Capital Raise Ford Credit Floorplan Master Owner Trust a

Ford Credit Floorplan Master Owner Trust a Capital Raise

Ford Credit Floorplan Master Owner Trust A entered into an underwriting agreement for the issuance of Series 2026-3 asset-backed notes. The offering involves multiple underwriters including Barclays, Deutsche Bank, and Mizuho, and is conducted under a shelf registration for asset-backed securities.

Counterparty
Barclays Capital Inc., Deutsche Bank Securities Inc., Mizuho Securities USA LLC, BMO Capital Markets Corp. and J.P. Morgan Securities LLC
6:52 AM ET 8-K
Capital Raise Atrium Therapeutics, Inc. RNA

Atrium Therapeutics Capital Raise of $50M

Atrium Therapeutics entered into a securities purchase agreement for a $50 million private placement (PIPE) involving the sale of 5,170,384 common shares and pre-funded warrants for 1,134,930 shares. The offering was priced at $7.93 per share and included participation from several institutional investors. Proceeds will be used to fund the development of lead product candidates and extend the company's cash runway through 2028.

Value
$50M
Counterparty
Sirenia Capital Management LP, Aberdeen Investments, Montanova, Sessa Capital, Casdin Capital
6:04 AM ET 8-K
Capital Raise Valion Bio, Inc. VBIO

Valion Bio Capital Raise

Valion Bio, Inc. entered into a letter agreement with 3i, LP to issue 50 shares of Series B Non-Voting Convertible Preferred Stock and warrants for 1,539 shares of common stock. The transaction resulted in gross proceeds of $50,000 as part of an ongoing securities purchase agreement. The warrants have an initial exercise price of $2.5520 per share.

Counterparty
3i, LP
6:01 AM ET 8-K
Capital Raise Leader's Advantage Acquisition Corp. LEDR

Leader's Advantage Acquisition Capital Raise of $155M

Leader's Advantage Acquisition Corp. completed its IPO of 15,000,000 units at $10.00 per unit, raising $150 million in gross proceeds. Simultaneously, the company raised an additional $5.43 million through private placements of shares to underwriters and warrants to its sponsor, with $151.125 million of total proceeds placed into a trust account.

Value
$155M
4:39 PM ET 8-K
Capital Raise Ares Industrial Real Estate Income Trust Inc.

Ares Industrial Real Estate Income Trust Capital Raise of $39.1M

Ares Industrial Real Estate Income Trust Inc. raised approximately $39.13 million in gross proceeds through the issuance of Class S-PR, Class D-PR, and Class I-PR shares between August 3, 2026, and October 1, 2026. The shares were issued in private placements exempt from registration under Regulation D and included activity from the company's distribution reinvestment plan.

Value
$39.1M
4:38 PM ET 8-K
Capital Raise Ares Real Estate Income Trust Inc. ZARE

Ares Real Estate Income Trust Capital Raise of $23.4M

Ares Real Estate Income Trust Inc. issued approximately 2.8 million shares of Class S-PR and Class I-PR common stock in unregistered private placements on October 1, 2026. The transactions generated total gross proceeds of approximately $23.4 million, which included activity from the company's distribution reinvestment plan.

Value
$23.4M
4:01 PM ET 8-K
Capital Raise North Haven Net REIT

North Haven Net REIT Capital Raise of $59.6M

North Haven Net REIT sold an aggregate of 2,835,825 common shares in its continuous private offering for approximately $59.6 million. The sale included Class S, Class F-I, Class I, and Class E common shares at the company's most recently determined net asset value per share.

Value
$59.6M
3:10 PM ET 8-K
Capital Raise Ares Core Infrastructure Fund

Ares Core Infrastructure Fund Capital Raise of $768M

Ares Core Infrastructure Fund agreed to sell multiple classes of common shares for an aggregate purchase price of $767.8 million in its October 2026 monthly closing. The shares were sold in an unregistered private placement exempt from registration requirements, with the price per share tied to the fund's net asset value as of September 30, 2026.

Value
$768M
2:42 PM ET 8-K
Capital Raise Invesco Commercial Real Estate Finance Trust, Inc. INCREF

Invesco Commercial Real Estate Finance Trust Capital Raise of $28.7M

Invesco Commercial Real Estate Finance Trust, Inc. sold 1,145,076 shares of common stock in an unregistered private placement on October 1, 2026. The offering raised approximately $28.7 million in aggregate consideration across Class S-1 and Class I shares, priced at the August 31, 2026 net asset value per share.

Value
$28.7M
2:09 PM ET 8-K
Capital Raise Goldman Sachs Real Estate Finance Trust Inc

Goldman Sachs Real Estate Finance Trust Capital Raise of $5.34M

Goldman Sachs Real Estate Finance Trust Inc sold unregistered shares of Class I and Class S common stock for aggregate consideration of approximately $5.34 million in an ongoing private offering. The company also announced monthly distributions for September 2026 and the origination of three new mortgage loans totaling $237.5 million across industrial and office properties.

Value
$5.34M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.